Prosecution Insights
Last updated: April 19, 2026
Application No. 17/438,095

NOVEL SOLVENT FOR EXTRACTING, SOLUBILISING AND/OR FORMULATING VOLATILE AND NON-VOLATILE COMPOUNDS OF INTEREST IN ANIMAL NUTRITION AND HEALTH, PREPARATION METHOD AND USES THEREOF

Non-Final OA §103§112§DP
Filed
Sep 10, 2021
Examiner
HOFFMAN, SUSAN COE
Art Unit
1655
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Avignon Université
OA Round
3 (Non-Final)
54%
Grant Probability
Moderate
3-4
OA Rounds
3y 0m
To Grant
80%
With Interview

Examiner Intelligence

Grants 54% of resolved cases
54%
Career Allow Rate
572 granted / 1058 resolved
-5.9% vs TC avg
Strong +26% interview lift
Without
With
+25.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 0m
Avg Prosecution
67 currently pending
Career history
1125
Total Applications
across all art units

Statute-Specific Performance

§101
9.5%
-30.5% vs TC avg
§103
34.8%
-5.2% vs TC avg
§102
17.4%
-22.6% vs TC avg
§112
26.9%
-13.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1058 resolved cases

Office Action

§103 §112 §DP
DETAILED ACTION 1. The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . 2. A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on June 6, 2025 has been entered. 3. Claims 1, 3-6, 8, 11-17, and 20-26 are pending. Election/Restrictions 4. In the reply filed on July 31, 2024, applicant elected Group I, now claims 1, 3-6, 11-17, and 20-26, chili for species A and sunflower oil for species B without traverse. 5. Claim 8 is withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. 6. Claims 1, 3-6, 11-17, and 20-26 are examined on the merits in regards to the elected species. Claim Rejections - 35 USC § 112 7. Claims 1, 3-6, 8, 11-17, and 20-21 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 is indefinite because it is unclear how many extraction steps are required by the claim. Lines 2-3 state that the process is drawn to “extract a biological active compound…in a solvent to form an extract.” However, line 5 then states that “the extract” is solubilized in “the solvent”. Line 5 appears to indicate that a second extraction step for “the extract” is performed. Claim 1 at lines 7-8 is indefinite because it states that solvent or mixture is heated to a temperature above 63°C “for at least the extracting of the biological active component.” The use of “at least” in this context is confusing because it is unclear what other effects on the solvent or the mixture are intended to be encompassed by “at least.” Claim Rejections - 35 USC § 103 8. Claim(s) 1, 3-6, 11-17, and 20-26 is/are rejected under 35 U.S.C. 103 as being unpatentable over Li (CN 103749743 A – English translation submitted by applicant in the IDS of June 6, 2025) in view of prior art admitted by applicant in the specification. Li teaches a process for the preparation of a product which comprises mixing chili oil resin (part of a vegetal matrix) with glycerin (glycerol) monolaurate and an additional oil such as sunflower oil. The reference teaches that the mixing process solubilizes the chili oil. The mixture is filtered and packaged. The resulting product is a food in oil form which is also considered to meet the structural limitations of an ointment (see translation). Li does not specifically teach heating the glycerol monolaurate or the mixture of the glycerol monolaurate and chili oil resin to a temperature above 63°C. However, the reference does teach that the glycerol monolaurate is liquid and that the combination of the ingredients is stirred (see pages 1 and 2 of the translation). Applicant’s specification admits that it was known in the art at the time of the invention that the melting point of glycerol monolaurate was 63°C (see paragraph 44). Thus, an artisan of ordinary skill would reasonably expect that the temperature of the mixture of the glycerol monolaurate and the chili oil resin should be increased to above 63°C to ensure that the glycerol monolaurate is in liquid form and is able to be stirred in combination with the chili oil as required by the reference. This reasonable expectation of success would have motivated the artisan to modify the reference to include increasing the temperature to above 63°C. The chili oil resin would be extracted from chili peppers prior to the mixture with the glycerol monolaurate. The reference does not specifically teach using dried or ground chili in the process. However, an artisan of ordinary skill would reasonably expect that dried or ground chili could be used as the source of the chili oil taught in the reference. This reasonable expectation of success would have motivated the artisan to modify the reference to include the use of dried or ground chili peppers in the process. In addition, the reference does not specifically teach using oleic, non-oleic, or hydrogenated sunflower oil in the process. However, these are known types of sunflower oil which would be obvious for one of skill in the art to employ as the sunflower oil ingredient in the reference. Double Patenting 9. Claims 1, 3-6, 11-17, and 20-26 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claim 1-10, 14, and 15 of copending Application No. 17/999,267 (reference application) for the reasons set forth in the previous Office action. Applicant has requested that this rejection be held in abeyance until allowable subject matter is indicated. The request is noted. The rejection is currently still considered valid at this time for the reasons set forth in the previous Office action. 10. No claims are allowed. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Susan Hoffman whose telephone number is (571)272-0963. The examiner can normally be reached M-Th 8:30am - 5:00pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Anand Desai can be reached at 571-272-0947. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SUSAN HOFFMAN/Primary Examiner, Art Unit 1655
Read full office action

Prosecution Timeline

Sep 10, 2021
Application Filed
Oct 15, 2024
Non-Final Rejection — §103, §112, §DP
Jan 16, 2025
Response Filed
Apr 03, 2025
Final Rejection — §103, §112, §DP
Jun 06, 2025
Response after Non-Final Action
Jul 01, 2025
Request for Continued Examination
Jul 07, 2025
Response after Non-Final Action
Mar 19, 2026
Non-Final Rejection — §103, §112, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12594313
COMPOSITION FOR RELIEVING CARDIOVASCULAR DISEASES OR OSTEOPOROSIS COMPRISING A MIXED EXTRACT OF HOP AND CYNANCHUM WILFORDII AND METHOD FOR TREATING OR ALLEVIATING CARDIOVASCULAR DISEASES OR OSTEOPOROSIS USING THE SAME
2y 5m to grant Granted Apr 07, 2026
Patent 12582674
Methods and Treatment of Trauma
2y 5m to grant Granted Mar 24, 2026
Patent 12569527
TETRASELMIS CHUII (T. CHUII) FOR THE TREATMENT OF MALE INFERTILITY
2y 5m to grant Granted Mar 10, 2026
Patent 12564606
PHARMACEUTICAL COMPOSITION FOR TREATING WOUNDS
2y 5m to grant Granted Mar 03, 2026
Patent 12564551
Composition or oat extract comprising avenanthramide and ß-glucan
2y 5m to grant Granted Mar 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
54%
Grant Probability
80%
With Interview (+25.7%)
3y 0m
Median Time to Grant
High
PTA Risk
Based on 1058 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month